LIFE SCIENCES & HEALTHCARE
Because innovation is everything
With increased regulatory scrutiny, pricing and cost pressures, as well as the rapid developments in genomic technology leading to a more personalised approach to medicine and healthcare, businesses and organisations in the life sciences and healthcare sector face a growing number of complex legal and regulatory challenges in order to stay competitive.
Our focus on business being changed by technology and the digital world enables us to support our clients operating in this rapidly changing environment. Our multidisciplinary team of 300 specialist life sciences and healthcare lawyers worldwide can advise you on every aspect of the business cycle of a life science and healthcare product or service, from incorporation through development to protection and exploitation of intellectual property.
We can advise you on:
- Technology transfers and IP Licensing
- R&D collaborations
- Patent and trade mark disputes and IP strategy
- Clinical trials
- Privacy and data protection
- Regulatory and data exclusivity
- Corporate transactions (including fundraising, IPOs and M&A)
- Competition law
- e-health, m-health and digitalisation
- Marketing arrangements and advertising
- Pricing and reimbursement
- Public procurement
- Product liability
- Employment
If you would like to know more about how we can help your business, please contact Heads of Group: Marc Martens in Brussels and Mark Hilton in London.
Related capabilities
Meet the Life Sciences and Healthcare team
See the full team
Discover the world of telemedicine
An international overview of the regulatory legislation
Case studies
More Case Studies
E-tablet helps deliver healthcare to marginalised communities
Delivering reliable healthcare to very rural communities across the globe, where digital records and diagnostics are not currently available, is a significant obstacle for United Nations institutions and NGOs. So, Arm, a leading technology provider of processor IP, partnered with Be he@lthy, be mobile, a World Health Organisation initiative, to develop a tech solution.
Latest insights
More Insights
Gen AI at work: Hong Kong Privacy Commissioner publishes further AI guidance on the use of Gen AI by employees
Apr 03 2025
Applications for provisional measures before the UPC – what may be granted?
5 minutes Mar 31 2025
English Court of Appeal uphold decision declaring that MSD had used “Merck” in breach of Court Order
3 minutes Mar 28 2025
Upcoming events
More Events
Accolades
Practitioners Guide to the UPC 1st Edition
Helping you navigate the practice and procedure of the Unified Patent Court and Unitary Patent.
LMG Life Sciences Awards EMEA 2023
Winner of Six Awards:
• EMEA M&A Firm of the Year
• EMEA Patent Litigation Firm of the Year: Medical Devices
• EMEA Venture Capital Firm of the Year
• Netherlands Firm of the Year
• Impact Case of the Year: Fingolimod
• Impact Deal of the Year: Dr Reddy’s Laboratories acquisition of Nimbus Health
LMG Life Sciences Awards EMEA 2024
Winner of 8 awards:
• Impact Deal of the Year: Envision Pharma acquisition of OKRA.ai
• Impact Case of the Year: Edwards Lifesciences v Meril Life Sciences
• Impact Case of the Year: Abbott Diabetes v Dexcom
• Impact Case of the Year: Xolair Litigations
• Impact Case of the Year: Stelara Litigations
• Impact Case of the Year: Gilead v Nucana
• Impact Case of the Year: Joined cases C-438/21, C-439/21, & C-440/21
• Netherlands Firm of the Year
